NYSE:NGVT Ingevity (NGVT) Stock Price, News & Analysis $38.79 -0.80 (-2.03%) Closing price 03:59 PM EasternExtended Trading$38.84 +0.06 (+0.15%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Ingevity Stock (NYSE:NGVT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ingevity alerts:Sign Up Key Stats Today's Range$37.77▼$39.6050-Day Range$39.62▼$48.7752-Week Range$30.90▼$56.30Volume154,079 shsAverage Volume267,468 shsMarket Capitalization$1.41 billionP/E RatioN/ADividend YieldN/APrice Target$55.17Consensus RatingModerate Buy Company OverviewIngevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.Read More… Remove Ads Ingevity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreNGVT MarketRank™: Ingevity scored higher than 59% of companies evaluated by MarketBeat, and ranked 101st out of 188 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingIngevity has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageIngevity has only been the subject of 1 research reports in the past 90 days.Read more about Ingevity's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth17.98% Earnings GrowthEarnings for Ingevity are expected to grow by 17.98% in the coming year, from $4.45 to $5.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ingevity is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ingevity is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIngevity has a P/B Ratio of 7.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Ingevity's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.36% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Ingevity has recently increased by 5.22%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIngevity does not currently pay a dividend.Dividend GrowthIngevity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.36% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Ingevity has recently increased by 5.22%, indicating that investor sentiment is decreasing significantly. News and Social Media2.9 / 5News Sentiment1.23 News SentimentIngevity has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Ingevity this week, compared to 4 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Ingevity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.10% of the stock of Ingevity is held by insiders.Percentage Held by Institutions91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Ingevity's insider trading history. Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Email Address NGVT Stock News HeadlinesIngevity (NYSE:NGVT) Downgraded to "Hold" Rating by StockNews.comMarch 25, 2025 | americanbankingnews.comIngevity Co. (NYSE:NGVT) Given Consensus Rating of "Moderate Buy" by AnalystsMarch 22, 2025 | americanbankingnews.comElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.April 1, 2025 | InvestorPlace (Ad)Ingevity Files Definitive Proxy Statement and Issues Letter to StockholdersMarch 20, 2025 | gurufocus.comIngevity Files Definitive Proxy Statement and Issues Letter to StockholdersMarch 20, 2025 | businesswire.comIngevity names David Li president, CEOMarch 11, 2025 | markets.businessinsider.comIngevity announces appointment of David H. Li as president and CEOMarch 10, 2025 | businesswire.comZacks.com featured highlights include Ingevity, Sterling Infrastructure, NVIDIA, PayPal and American AirlinesMarch 5, 2025 | finance.yahoo.comSee More Headlines NGVT Stock Analysis - Frequently Asked Questions How have NGVT shares performed this year? Ingevity's stock was trading at $40.75 on January 1st, 2025. Since then, NGVT stock has decreased by 6.4% and is now trading at $38.1550. View the best growth stocks for 2025 here. How were Ingevity's earnings last quarter? Ingevity Co. (NYSE:NGVT) released its quarterly earnings data on Tuesday, February, 18th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.66. The company earned $298.80 million during the quarter, compared to analysts' expectations of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive trailing twelve-month return on equity of 41.44%. How do I buy shares of Ingevity? Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), Humana (HUM), AUO (AUOTY), The RMR Group (RMR) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings2/18/2025Today4/01/2025Next Earnings (Estimated)4/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBasic Materials Industry Chemicals & allied products Sub-IndustryChemicals Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CIK1653477 Webwww.ingevity.com Phone(843) 740-2300Fax843-740-8165Employees2,050Year FoundedN/APrice Target and Rating Average Stock Price Target$55.17 High Stock Price Target$65.00 Low Stock Price Target$40.00 Potential Upside/Downside+42.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($11.84) Trailing P/E RatioN/A Forward P/E Ratio8.68 P/E GrowthN/ANet IncomeN/A Net Margins-30.60% Pretax Margin-38.08% Return on Equity41.44% Return on Assets5.76% Debt Debt-to-Equity Ratio6.86 Current Ratio1.87 Quick Ratio1.04 Sales & Book Value Annual Sales$1.41 billion Price / Sales1.00 Cash Flow$13.32 per share Price / Cash Flow2.90 Book Value$5.37 per share Price / Book7.19Miscellaneous Outstanding Shares36,439,000Free Float35,949,000Market Cap$1.41 billion OptionableOptionable Beta1.53 Social Links The 10 Best Stocks to Own: Spring 2025Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.Get This Free Report This page (NYSE:NGVT) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ingevity Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ingevity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.